Silverado Hospice, Inc. v. Xavier Becerra ( 2022 )


Menu:
  •                     FOR PUBLICATION
    UNITED STATES COURT OF APPEALS
    FOR THE NINTH CIRCUIT
    SILVERADO HOSPICE, INC., a                      No. 20-56348
    Delaware corporation; PROCARE
    HOSPICE, LLC, a Delaware limited                  D.C. Nos.
    liability corporation,                         8:19-cv-01007-
    Plaintiffs-Appellants,          DMG-RAO
    8:19-cv-01098-
    v.                           DMG-RAO
    2:19-cv-05096-
    XAVIER BECERRA, Secretary of                     DMG-RAO
    United States Department of Health
    and Human Services,
    Defendant-Appellee.               OPINION
    Appeal from the United States District Court
    for the Central District of California
    Dolly M. Gee, District Judge, Presiding
    Argued and Submitted March 18, 2022
    San Francisco, California
    Filed August 1, 2022
    Before: Morgan Christen and Daniel A. Bress, Circuit
    Judges, and Barbara M. G. Lynn, * District Judge.
    Opinion by Judge Bress
    *
    The Honorable Barbara M. G. Lynn, Chief United States District
    Judge for the Northern District of Texas, sitting by designation.
    2              SILVERADO HOSPICE V. BECERRA
    SUMMARY **
    Medicare
    The panel affirmed the district court’s summary
    judgment in favor of the government in an action brought by
    hospice providers who alleged that the Centers for Medicare
    and Medicaid Services’ method of implementing the Budget
    Control Act’s across-the-board cuts for hospice
    reimbursements was contrary to the Medicare statute and the
    Budget Control Act.
    This case involves the complex interaction between two
    statutory limits on federal Medicare spending relating to
    hospice care. Hospices that treat Medicare beneficiaries
    receive periodic reimbursements throughout the year from
    the Centers for Medicare and Medicaid Services (“CMS”),
    but the Medicare statute caps hospices’ aggregate annual
    reimbursement. The Budget Control Act separately requires
    the federal government to implement across-the-board
    cuts—commonly known as “sequestration”—to direct
    spending programs (including Medicare) when certain
    statutory conditions are met, as they were here.
    The triggering of sequestration required CMS to
    determine how to cut hospice spending in a manner
    consistent with the Medicare statute’s cap requirements.
    CMS ultimately issued a technical direction letter (“TDL”)
    to its Medicare Administrative Contractors (“MAC”)
    providing instructions on how to address sequestration
    amounts relating to the cap calculation. The TDL explained
    **
    This summary constitutes no part of the opinion of the court. It
    has been prepared by court staff for the convenience of the reader.
    SILVERADO HOSPICE V. BECERRA                  3
    that its overpayment calculation method would apply
    retroactively to the 2013 and 2014 fiscal years.
    The plaintiff hospices exceeded their aggregate caps in
    the 2013 fiscal year, and three Silverado hospices also
    exceeded their aggregate caps in the 2014 fiscal year. In
    2015, plaintiffs’ MACs issued notices of its aggregate cap
    determinations for both fiscal years. In each of the eight
    notices, the MAC included the details of its cap calculations
    under the TDL’s multi-step method and requested refunds of
    the overpayment amounts. Plaintiffs appealed their cap
    determinations to the Provider Reimbursement Review
    Board (“PRRB”), arguing that their MAC had failed to
    calculate the aggregate cap using the “actual net amount of
    payment received by the hospice provider.” Instead, the
    MAC had calculated their overpayments using the TDL
    method. Plaintiffs argued that the MAC’s calculation
    method was contrary to 42 U.S.C. § 1395f(i)(2)(A), which
    specifies how the aggregate cap is calculated. The PRRP
    upheld the MAC’s overpayment calculations.
    The panel held that CMS correctly concluded that the
    Budget Control Act required it to reduce the total annual
    amounts paid to hospices, not only the periodic
    reimbursements, and that the agency’s chosen method for
    implementing sequestration was consistent with the
    Medicare statute. CMS adopted a method that harmonized
    the Budget Control Act and the Medicare statute, ensuring
    the necessary percentage reduction to Medicare spending
    without altering the statutorily mandated calculation of the
    annual hospice cap. Plaintiffs’ preferred method, by
    contrast, would not achieve sequestration’s required
    spending reductions.
    4            SILVERADO HOSPICE V. BECERRA
    Having concluded that the Budget Control Act required
    a reduction in annual hospice payments, and not just periodic
    reimbursements, the panel next considered whether the
    agency’s chosen method was consistent with other language
    in the Medicare statute, and specifically the cap calculation
    methodology. The panel held that it was. The statute’s plain
    language established that the “amount of payment made”
    does not refer to historical, periodic reimbursements, but
    rather the payment to which a hospice is legally entitled in a
    fiscal year.
    Finally, the panel held that the agency was not required
    to undertake notice-and-comment rulemaking before
    implementing the Budget Control Act’s sequestration
    mandate. The agency’s sequestration method, as reflected
    in the TDL and the PRRB’s decisions, did not amount to the
    “establish[ment]” or “change[]” of a substantive legal
    standard governing payment for services under Medicare,
    within the meaning of 42 U.S.C. § 1395hh. Rather,
    Congress enacted the Budget Control Act’s sequestration
    requirements, and the President implemented sequestration
    when the statutory conditions were triggered.
    COUNSEL
    Brian M. Daucher (argued), Sheppard Mullin Richter &
    Hampton LLP, Costa Mesa, California; Matthew G.
    Halgren, Sheppard Mullin Richter & Hampton LLP, San
    Diego, California; for Plaintiffs-Appellants.
    McKaye L. Neumeister (argued) and Michael S. Raab,
    Appellate Staff; Tracy L. Wilkison, Acting United States
    Attorney; Brian M. Boynton, Acting Assistant Attorney
    General; Civil Division, United States Department of
    SILVERADO HOSPICE V. BECERRA                   5
    Justice, Washington, D.C.; Daniel J. Barry, Acting General
    Counsel; Janice L. Hoffman, Associate General Counsel;
    Susan Maxson Lyons, Deputy Associate General Counsel
    for Litigation; W. Charles Bailey Jr., Attorney; United States
    Department of Health & Human Services, Washington,
    D.C.; for Defendant-Appellee.
    W. Jerad Rissler, Arnal Golden Gregory LLP, Atlanta,
    Georgia; William A. Dombi, Director, Center for Health
    Law, Washington, D.C.; for Amicus Curiae National
    Association for Home Care & Hospice.
    OPINION
    BRESS, Circuit Judge:
    This case involves the complex interaction between two
    statutory limits on federal Medicare spending relating to
    hospice care. Hospices that treat Medicare beneficiaries
    receive periodic reimbursements throughout the year from
    the Centers for Medicare and Medicaid Services (CMS), but
    the Medicare statute caps hospices’ aggregate annual
    reimbursement. The Budget Control Act separately requires
    the federal government to implement across-the-board
    cuts—commonly known as “sequestration”—to direct
    spending programs (including Medicare) when certain
    statutory conditions are met, as they were here.
    The plaintiffs are hospice providers who allege that
    CMS’s method of implementing sequestration for hospice
    reimbursements is contrary to the Medicare statute and the
    Budget Control Act. We conclude that the plaintiffs’
    challenge is without merit. CMS adopted a method that
    harmonized the Budget Control Act and the Medicare
    statute, ensuring the necessary percentage reduction to
    6            SILVERADO HOSPICE V. BECERRA
    Medicare spending without altering the statutorily mandated
    calculation of the annual hospice cap. Plaintiffs’ preferred
    method, by contrast, would not achieve sequestration’s
    required spending reductions. For these reasons and those
    that follow, we affirm the district court’s grant of summary
    judgment to the government.
    I
    Silverado Hospice, Inc. and ProCare Hospice, LLC
    operate Medicare-certified hospices in Southern California,
    five of which are at issue here. Some of the hospices’
    patients are elderly or disabled individuals who receive
    palliative care and whose treatment is covered by their
    insurance under Medicare Part A. 42 U.S.C. § 1395d(d). A
    Medicare beneficiary is eligible for hospice benefits if he or
    she is terminally ill, meaning a life expectancy of six months
    or less. Id. § 1395f(a)(7)(A); id. § 1395x(dd)(3)(A).
    CMS administers the hospice benefit on behalf of the
    Department of Health and Human Services (HHS). Part of
    the agency’s responsibility entails controlling the program’s
    costs, while ensuring that hospices are properly reimbursed
    for their care of Medicare beneficiaries. We start with the
    relevant background on hospice reimbursements, which
    frames this dispute.
    A
    Medicare reimbursements for hospice care are partially
    a matter of timing. So that hospices receive funds
    throughout the year for the care they provide to Medicare
    beneficiaries, CMS periodically reimburses hospices using a
    Medicare      Administrative    Contractor   (MAC)       as
    intermediary.      See 42 U.S.C. § 1395g(a); id.
    § 1395h(c)(2)(A)–(B); 
    42 C.F.R. § 418.302
    (d)–(e). The
    SILVERADO HOSPICE V. BECERRA                   7
    reimbursements are based on a pre-set, per-patient amount
    for each day that a hospice provides care to a Medicare
    beneficiary. 42 U.S.C. § 1395f(i)(1); see also 
    42 C.F.R. §§ 418.302
    , 418.306; Back v. Sebelius, 
    684 F.3d 929
    , 930
    (9th Cir. 2012).
    However, the reimbursements are subject to an aggregate
    annual cap per hospice facility.         See 42 U.S.C.
    § 1395f(i)(2)(A); 
    42 C.F.R. § 418.308
    (a); L.A. Haven
    Hospice, Inc. v. Sebelius, 
    638 F.3d 644
    , 649–50 (9th Cir.
    2011). The Medicare statute provides:
    The amount of payment made under this part
    for hospice care provided by . . . a hospice
    program for an accounting year may not
    exceed the “cap amount” for the year
    (computed under subparagraph (B))
    multiplied by the number of medicare
    beneficiaries in the hospice program in that
    year (determined under subparagraph (C)).
    42 U.S.C. § 1395f(i)(2)(A). The aggregate cap is calculated
    retrospectively at the close of each fiscal year, based on how
    many unique patients a hospice treated that year. 
    42 C.F.R. § 418.308
    (c). A hospice whose Medicare reimbursements
    exceeded the aggregate cap must repay the difference. 
    Id.
     at
    § 418.308(d). For example, if a MAC made $1,200 in
    periodic payments throughout the year but the hospice is
    subject to a $1,000 annual cap, the hospice would need to
    remit $200 at the end of the fiscal year. About ten percent
    of hospices exceeded the cap in 2010.
    The precise calculation of the aggregate cap amount is
    determined based on 42 U.S.C. § 1395f(i)(2)(B)–(C).
    Section 1395f(i)(2)(B) provides the calculation for the per-
    patient cap amount, which is in turn multiplied by the
    8            SILVERADO HOSPICE V. BECERRA
    “number of medicare beneficiaries” as determined by
    § 1395f(i)(2)(C). Id. § 1395f(i)(2)(A). In 1984, the
    aggregate cap’s first year, the per-patient cap amount was
    $6,500. Id. § 1395f(i)(2)(B)(i). But the per-patient amount
    was indexed to inflation and rose to $26,157.50 in 2013, the
    first fiscal year at issue here. Id.; Medicare Program; FY
    2015 Hospice Wage Index and Payment Rate Update,
    
    79 Fed. Reg. 50,452
    , 50,471 (Aug. 22, 2014). The Medicare
    regulations also provide detailed rules for counting the
    “number of medicare beneficiaries” a hospice treats in a
    fiscal year. See 42 U.S.C. § 1395f(i)(2)(C); 
    42 C.F.R. § 418.309
    (b)(2). The parties do not dispute the method of
    calculating the per-patient cap amount. Nor do they dispute
    the method for determining the “number of medicare
    beneficiaries.”
    Once a fiscal year ends, hospices have five months to
    self-determine their aggregate cap amounts, file notice with
    their MACs, and “remit any overpayment due.” 
    42 C.F.R. § 418.308
    (c). The MAC then “issues the final cap
    determination” and “reconcile[s] the final payments” to the
    hospice. 79 Fed. Reg. at 50,473. If the MAC determines
    that a hospice exceeded the aggregate cap and has an
    outstanding overpayment, the MAC’s letter containing the
    “final determination of program reimbursement” also
    includes a demand for repayment. 
    42 C.F.R. § 405.1803
    (a)–
    (b); 
    id.
     § 418.308(c).
    If a hospice disputes the MAC’s final cap determination,
    and the amount in controversy is at least $10,000, the
    hospice can appeal to the Provider Reimbursement Review
    Board (PRRB), an HHS tribunal.              See 42 U.S.C.
    § 1395oo(a). Unless the Administrator of CMS elects to
    review it, the PRRB’s decision constitutes HHS’s final
    decision.      42 U.S.C. § 1395oo(f)(1); 42 C.F.R.
    SILVERADO HOSPICE V. BECERRA                9
    § 405.1875(a). A hospice can then obtain judicial review of
    the agency’s final decision in federal court. 42 U.S.C.
    § 1395oo(f)(1).
    B
    The aggregate annual cap is not the only restriction on
    Medicare’s hospice spending. The Balanced Budget and
    Emergency Deficit Control Act of 1985, Pub. L. No. 99-177,
    
    99 Stat. 1038
    , as amended by the Budget Control Act of
    2011, Pub. L. No. 112-25, 
    125 Stat. 240
    , requires the
    President to make automatic spending cuts (the
    aforementioned “sequestration”) to federal spending when
    certain statutory conditions are triggered. See 
    2 U.S.C. §§ 900
    –03. When sequestration is triggered, the President
    must reduce the federal government’s direct spending by a
    certain percentage based on the Budget Control Act’s
    mandates.
    The Budget Control Act generally requires the Office of
    Management and Budget (OMB) to calculate a uniform
    percentage by which the budgets of nonexempt spending
    programs are to be sequestered. See 2 U.S.C. §§ 901a(6),
    935(a)(1). Certain spending programs, however, are exempt
    from sequestration. 
    2 U.S.C. § 905
    . Although Medicare
    Part A is not exempt, the Budget Control Act has special
    rules for Medicare sequestration. See 
    id.
     §§ 901a(6)(A),
    906(d).
    Relevant here, the Budget Control Act limits the
    sequestration of spending for certain Medicare programs to
    a flat two percent across-the-board reduction.          Id.
    § 901a(6)(A). One type of Medicare spending subject to the
    two-percent reduction is “individual payments for services
    furnished” under Medicare Part A, which covers hospice
    care. Id. §§ 901a(6)(A), 906(d)(1)(A). To secure the proper
    10            SILVERADO HOSPICE V. BECERRA
    “total percentage reduction” in covered “programs,” the
    Budget Control Act requires that the two-percent reduction
    in “individual payments for services furnished” during a
    given fiscal year be applied “such that the reduction made in
    payments . . . shall achieve the required total percentage
    reduction in those payments for that period.”             Id.
    § 906(d)(1).
    In March 2013, the statutory conditions for sequestration
    were triggered. The President accordingly signed a
    sequestration order requiring federal agencies to implement
    spending reductions, as calculated by OMB.                See
    Sequestration Order for Fiscal Year 2013, 
    78 Fed. Reg. 14,633
     (Mar. 1, 2013). Beginning the following month,
    MACs reduced their periodic reimbursements to hospices by
    two percent. When these periodic payments were made, it
    remained to be seen whether the hospices would ultimately
    exceed their cap amounts at the end of the year. Although
    only the 2013 and 2014 fiscal years are at issue here,
    sequestration has also been implemented every year since.
    C
    The triggering of sequestration required CMS to
    determine how to cut hospice spending in a manner
    consistent with the Medicare statute’s cap requirements.
    Although one might think that reducing spending by two
    percent should not be so difficult, it turns out that the matter
    is somewhat involved. It is complex because having reduced
    periodic payments by two percent, the agency then had to
    devise a back-end reconciliation procedure that addressed
    both the aggregate cap and the prior payments. And the
    agency had to do so in a way that complied with the Budget
    Control Act, the Medicare statute, and Medicare regulations.
    SILVERADO HOSPICE V. BECERRA                 11
    After a period of uncertainty about what the rules should
    be, CMS ultimately issued a technical direction letter (TDL)
    to its MACs providing instructions on how to address
    sequestration amounts relating to the cap calculation. The
    TDL explained that its overpayment calculation method
    would apply retroactively to the 2013 and 2014 fiscal years.
    Although hospice providers were frustrated by the apparent
    revision in how some MACs were assessing amounts owed
    for cap overages, the agency concluded that its methodology
    was necessary to implement sequestration.
    The TDL established a multi-step process for reconciling
    the aggregate cap with the Budget Control Act’s required
    two-percent reduction in Medicare Part A spending. First,
    the MAC adds amounts withheld from a hospice provider’s
    periodic reimbursements due to sequestration—that is, the
    two percent skimmed off the top of every reimbursement
    throughout the year—to the aggregate periodic
    reimbursement actually paid. This sum is the pre-
    sequestration reimbursement amount. It is equivalent to
    what the hospice’s aggregate reimbursement amount would
    have been, but for sequestration.
    Second, the MAC compares the pre-sequestration
    reimbursement amount to the hospice’s aggregate cap,
    calculated as specified in § 1395f(i)(2). If the pre-
    sequestration reimbursement amount exceeds the aggregate
    cap, the difference between the two amounts is the pre-
    sequestration overpayment amount. In other words, it is the
    amount the hospice would have received in excess of the
    aggregate cap, but for sequestration.
    Third, if there is an overpayment amount, the MAC
    reduces the amount by two percent to reflect the actual
    overpayment the hospice received. This sum constitutes the
    12            SILVERADO HOSPICE V. BECERRA
    post-sequestration overpayment amount that the provider
    must remit to the MAC.
    If this sounds complicated, it is. But a helpful chart used
    in Gentiva Health Services, Inc. v. Cochran, 
    523 F. Supp. 3d 81
    , 88 (D.D.C. 2021), aff’d, 
    31 F.4th 766
     (D.C. Cir. 2022),
    and reproduced by the government in its brief, illustrates the
    TDL’s multi-step method by comparing a hypothetical
    Hospice A that met its $1,000 cap to a hypothetical Hospice
    B that exceeded it by $200:
    CMS TDL Method
    Hospice Hospice
    A       B
    A. Annual Aggregate Cap                   $1,000 $1,000
    B. Actual Preliminary Payments              $980 $1,176
    C. Sequestered Amount                        $20    $24
    D. Pre-sequestration                      $1,000 $1,200
    Reimbursement Amount (B+C)
    E. Pre-sequestration Amount in                 $0      $200
    Excess of Cap (D-A)
    F. 2% of the Pre-Sequester Amount              $0         $4
    Overpayment
    G. Revised Payment in Excess of                $0      $196
    Cap (E-F)
    H. Final Amount Retained by                 $980       $980
    Hospice (B-G)
    While the agency’s method is complex, its ultimate
    effect is clear: each hospice ultimately receives 98% of the
    compensation it would have received but for sequestration.
    This means hospices that exceed the aggregate cap, even
    with two percent of their periodic reimbursements being
    withheld throughout the year, still have their total annual
    SILVERADO HOSPICE V. BECERRA                 13
    capped reimbursement amount reduced by two percent.
    Under the agency’s sequestration method, Hospice B would
    repay $196 and, like Hospice A, would retain $980.
    Under plaintiffs’ preferred method, by contrast, CMS
    would only sequester two percent of the periodic
    reimbursements that hospices receive during the fiscal year.
    If a hospice reached or exceeded its aggregate cap even with
    reduced periodic reimbursements, as the plaintiff hospices
    here did, then based on the cap it would see no reduction in
    the total amount of payment it kept at year end under
    sequestration. Using the chart above, if the agency adopted
    plaintiffs’ preferred method, Hospice B would have to repay
    only $176 (B minus A in the above chart) and would retain
    $1,000—the same amount that it would have retained before
    sequestration was implemented. But the agency rejected
    plaintiffs’ method.
    D
    The plaintiff hospices exceeded their aggregate caps in
    the 2013 fiscal year, and the three Silverado hospices also
    exceeded their aggregate caps in the 2014 fiscal year. In
    2015, plaintiffs’ MAC issued notices of its aggregate cap
    determinations for both fiscal years. In each of the eight
    notices, the MAC included the details of its cap calculations
    under the TDL’s multi-step method and requested refunds of
    the overpayment amounts. To give a sense of the numbers,
    comparing the TDL calculation method to plaintiffs’ desired
    method, for Silverado’s three hospices in fiscal year 2014,
    the disputed repayment amounts were $116,649.59,
    $36,104.78, and $129,920.95.
    Plaintiffs appealed their cap determinations to the
    PRRB. They argued that their MAC had failed to calculate
    the aggregate cap using the “actual net amount of payment
    14            SILVERADO HOSPICE V. BECERRA
    received by the hospice provider.” The MAC had calculated
    their overpayments using the TDL method we described
    above. But plaintiffs argued that the MAC’s calculation
    method was contrary to § 1395f(i)(2)(A), which specifies
    how the aggregate cap is calculated.
    The PRRB upheld the MAC’s overpayment calculations.
    The PRRB concluded that “nothing in the Medicare statutory
    or regulatory provisions governing hospice payment”
    required MACs to use the “net reimbursement to the
    hospice.” Rather, the terms “amount paid” and “amount of
    payment” in the Medicare statute had to be “viewed on a cap
    year basis,” and it was to the aggregate year-end amount that
    sequestration applied. The PRRB also recognized that, if
    CMS had directed MACs to pay periodic reimbursements
    without any reductions and then apply the two percent
    reduction only at the end of the fiscal year, “assessing and
    collecting overpayments on all Medicare-participating
    hospices . . . would not be administratively practicable.”
    The Administrator of CMS declined to review the PRRB’s
    decisions.
    Plaintiffs filed three actions in federal court, which were
    then consolidated.         The district court granted the
    government’s motion for summary judgment. The district
    court concluded that CMS was required to reduce its total
    hospice spending for the year, and that the agency’s method
    did so in a manner consistent with the Medicare statute.
    II
    We review de novo the district court’s summary
    judgment decision. KST Data, Inc. v. DXC Tech. Co.,
    
    980 F.3d 709
    , 713 (9th Cir. 2020). We set aside the agency’s
    decisions under the Administrative Procedure Act if they are
    “arbitrary, capricious, an abuse of discretion, or otherwise
    SILVERADO HOSPICE V. BECERRA                  15
    not in accordance with law.” 42 U.S.C. § 1395oo(f)(1);
    
    5 U.S.C. § 706
    (2)(A).
    We hold that CMS correctly concluded that the Budget
    Control Act required it to reduce the total annual amounts
    paid to hospices, not only the periodic reimbursements, and
    that the agency’s chosen method for implementing
    sequestration is consistent with the Medicare statute.
    Plaintiffs’ preferred method, by contrast, would not reduce
    hospice spending by the required two percent.
    A
    The relevant provision of the Budget Control Act, as it
    applies to Medicare programs, provides:
    To achieve the total percentage reduction in
    those programs required by section 902 or
    903 of this title . . . OMB shall determine . . .
    the percentage reduction that shall apply,
    with respect to the health insurance programs
    under title XVIII of the Social Security Act—
    (A) in the case of Parts A and B of such
    title, to individual payments for services
    furnished during the one-year period . . .
    such that the reduction made in payments
    under that order shall achieve the required
    total percentage reduction in those payments
    for that period.
    
    2 U.S.C. § 906
    (d)(1).
    CMS interpreted § 906(d)(1) to require a two-percent
    reduction in the total annual payment made to a hospice
    16           SILVERADO HOSPICE V. BECERRA
    provider, after application of the annual cap amount.
    Plaintiffs argue, however, that “individual payments” for
    Medicare Part A in § 906(d)(1)(A) refers to hospices’
    periodic reimbursements.         They thus contend that
    § 906(d)(1)(A) required only a reduction in the periodic
    reimbursement amounts, not the total annual amounts.
    Plaintiffs acknowledge that Congress could have applied
    sequestration to a hospice’s aggregate annual payments after
    application of the cap, but insist that Congress instead
    referred only to periodic reimbursements.
    Plaintiffs are mistaken. The “individual payments for
    services” referenced in § 906(d)(1), read in context with the
    rest of the Budget Control Act, does not refer to hospices’
    periodic reimbursements. The Budget Control Act is
    concerned with reducing federal spending on “the health
    insurance programs,” not just some preliminary spending
    components of those programs. See id. § 906(d)(1)
    (emphasis added). The relevant “program” here is Medicare
    Part A. This is the “direct spending” that the Budget Control
    Act requires the agency to reduce. See id. § 901a(6)(A); see
    also id. § 901a(7) (referencing “the percentage reduction for
    the Medicare programs”).          That is consistent with
    § 906(d)(1)’s mandate to achieve a “total percentage
    reduction.” The “total” here is keyed off the cap amount
    because the periodic reimbursements are effectively
    preliminary in nature, always subject to the cap rules
    requiring year-end reconciliation.
    To accept plaintiffs’ contrary interpretation of
    § 906(d)(1), meanwhile, would be to conclude that hospices
    whose sequestration-reduced periodic reimbursements
    nonetheless exceed their aggregate caps face no annual
    reduction in their reimbursements. The implication of
    plaintiffs’ argument is that Congress, in attempting to enact
    SILVERADO HOSPICE V. BECERRA                  17
    across-the-board cuts to federal spending, in fact failed to
    reduce Medicare Part A spending for certain hospices by the
    intended percentage. We are hesitant to read such a result
    into § 906(d)(1) because we do “not lightly conclude that
    Congress enacted a self-defeating statute.” Quarles v.
    United States, 
    139 S. Ct. 1872
    , 1879 (2019).
    To illustrate the implications of plaintiffs’ position, we
    could imagine that ten hospices receive reimbursements, the
    aggregate cap is $100, nine hospices qualify for exactly $100
    in pre-sequestration periodic reimbursements, and the
    remaining hospice qualifies for $110. Before sequestration,
    the government’s spending would be $1,000 (the $100
    aggregate cap across ten hospices). After sequestration’s
    two-percent reduction, we would expect the government to
    spend $980. Applying two-percent reductions to periodic
    reimbursements throughout the year, the first nine hospices
    would be paid $98 and the tenth would be paid $107.80. The
    first nine would be under the cap and would owe the
    government nothing. The tenth would be over the cap.
    Under the agency’s method, the tenth hospice would repay
    $9.80, putting total program spending at $980. Under
    plaintiffs’ proposed method, the tenth hospice would only
    repay $7.80. In that case, the government’s total spending
    would be $982—only a 1.8% reduction. Accepting
    plaintiffs’ argument would be tantamount to concluding that
    the Budget Control Act failed to achieve its desired
    objective. And it would produce the anomalous result that
    hospices operating below their caps face a two percent
    reduction, but hospices that exceed their caps do not.
    Fortunately, we need not conclude that Congress
    intended this anomaly because the Budget Control Act and
    the Medicare statute can be read harmoniously. When we
    combine the Budget Control Act’s mandate to reduce
    18            SILVERADO HOSPICE V. BECERRA
    “individual payments,” 
    2 U.S.C. § 906
    (d)(1)(A), with the
    Medicare statute’s description of what constitutes “payment
    for hospice care,” 42 U.S.C. § 1395f(i), it becomes clear that
    the relevant payment that must be reduced during
    sequestration is the aggregate amount that a hospice is
    legally entitled to for a fiscal year. It is not just the periodic
    reimbursements that a hospice receives throughout the year
    that must be reduced.
    The relevant portion of the Medicare statute, § 1395f(i),
    is titled “payment for hospice care.” The statute provides
    that “the amount paid to a hospice program with respect to
    hospice care for which payment may be made” is “[s]ubject
    to the limitation” of § 1395f(i)(2), which is the aggregate
    cap. Id. § 1395f(i)(1). The aggregate cap provision, in turn,
    specifies that the “amount of payment made under this part
    for hospice care provided by . . . a hospice program for an
    accounting year may not exceed” the aggregate cap. Id.
    § 1395f(i)(2). These provisions of the Medicare statute
    contemplate “payment” being determined in the aggregate,
    based on the fiscal year as a whole. They do not refer to
    periodic reimbursements. Reimbursements that exceed the
    aggregate cap at the end of the fiscal year are not “payment
    for hospice care” to which a hospice is legally entitled under
    § 1395f(i)(1).
    Taking § 906(d)(1) of the Budget Control Act and
    § 1395f(i) of the Medicare statute together, then, it is clear
    that the statutes require the agency to reduce the total annual
    payment that hospices receive by two percent. This
    requirement necessarily applies when a hospice exceeds the
    aggregate cap. In that event, the agency must reduce the
    amount that the hospice would receive after application of
    the aggregate cap because the cap amount is the amount that
    SILVERADO HOSPICE V. BECERRA                   19
    the agency otherwise would have paid the hospice absent
    sequestration.
    When courts can “interpret statutes to be coherent and
    internally consistent,” they should. Freeman v. Gonzales,
    
    444 F.3d 1031
    , 1039 (9th Cir. 2006). Here, the “text,
    context, and structure” of the Budget Control Act and the
    Medicare statute confirm that the agency was required to
    reduce the annual amounts paid to hospices by two percent.
    See Becerra v. Empire Health Found., 
    142 S. Ct. 2354
    , 2368
    (2022) (noting in a recent challenge to HHS reimbursements
    that “[t]ext, context, and structure all support calculating the
    Medicare fraction HHS’s way.”).
    B
    Having concluded that the Budget Control Act required
    a reduction in annual hospice payments, and not just periodic
    reimbursements, we now consider whether the agency’s
    chosen method is consistent with other language in the
    Medicare statute, and specifically the cap calculation
    methodology. We hold that it is.
    The Medicare statute specifies that the “amount of
    payment made under this part for hospice care . . . for an
    accounting year may not exceed the ‘cap amount’ for the
    year (computed under subparagraph (B)) multiplied by the
    number of medicare beneficiaries in the hospice program in
    that year (determined under subparagraph (C)).” 42 U.S.C.
    § 1395f(i)(2)(A) (emphasis added). On this point, the
    parties’ dispute turns on the meaning of the italicized phrase.
    Plaintiffs maintain that “amount of payment made” should
    be interpreted as “payments actually made” to a hospice
    during a fiscal year, such that the agency can determine
    overpayment amounts only by factoring in actual, historical
    payments that the hospices received, without adding in the
    20            SILVERADO HOSPICE V. BECERRA
    sequestered portions of periodic reimbursements that
    hospices did not receive. For its part, the agency does not
    interpret “amount of payment made” to refer to actual,
    historical periodic reimbursements, but rather to the amount
    that a hospice is legally entitled to in a fiscal year.
    The agency’s interpretation is the much better one. As a
    textual matter, the Medicare statute does not contain any
    reference to historic or “actual” payments made, but instead
    places a legal limit—in the form of the aggregate cap—on
    the amount that a hospice can be reimbursed in a given fiscal
    year. 42 U.S.C. § 1395f(i)(2). And the word “made” is not
    the past tense of a verb, as plaintiffs contend, but a past
    participle that functions as an adjective and takes the passive
    voice. See Gentiva Health Servs., Inc. v. Becerra, 
    31 F.4th 766
    , 776 (D.C. Cir. 2022). It places an upper bound on the
    amount of reimbursement a hospice can receive; it does not
    refer to past periodic reimbursements.
    As a logical matter, too, “amount of payment made”
    cannot refer to payments “actually” made. If it did,
    § 1395f(i)(2) would require the agency to ensure that
    periodic reimbursements to a hospice do not exceed an
    amount that can only be determined months, and sometimes
    years, later. See 79 Fed. Reg. at 50,473 (noting that hospices
    must “wait at least 3 months after the end of the cap year”
    before self-determining aggregate cap overpayments). Even
    once final cap determinations are calculated after the close
    of a fiscal year, there can be subsequent adjustments to a
    hospice’s cap that could require the hospice to remit further
    overpayment amounts.          See 42 U.S.C. § 1395g(a)
    (contemplating “necessary adjustments” to the amount owed
    to a Medicare provider “on account of previously made
    overpayments       or     underpayments”);      
    42 C.F.R. § 418.309
    (b)(2) (“The aggregate cap calculation for a given
    SILVERADO HOSPICE V. BECERRA                         21
    cap year may be adjusted after the calculation for that year
    based on updated data.”). The statute’s plain language thus
    establishes that the “amount of payment made” does not
    refer to historical, periodic reimbursements, but rather the
    payment to which a hospice is legally entitled in a fiscal year.
    See 42 U.S.C. § 1395f(i)(2)(A). 1
    The Medicare statute does require that the aggregate cap
    itself be calculated according to § 1395f(i)(2)(B) and (C).
    But that point is inapposite here, making plaintiffs’ reliance
    on Los Angeles Haven Hospice, Inc. v. Sebelius, 
    638 F.3d 644
     (9th Cir. 2011), and Lion Health Services, Inc. v.
    Sebelius, 
    635 F.3d 693
     (5th Cir. 2011), misplaced. Both
    decisions invalidated a regulation that purported to alter the
    aggregate cap calculation itself, contrary to the statute. Here,
    by contrast, the agency has not altered the statutory method
    by which the aggregate cap is calculated. Rather, the agency
    has validly interpreted “amount of payment made” to include
    the sequestered portions of hospices’ periodic
    reimbursements, and to not be limited to amounts actually
    paid to hospices after the sequestered portions are withheld.
    In short, the agency’s sequestration method is driven by
    three considerations. First, the Budget Control Act requires
    a reduction in the total amount of payment to which a
    hospice is entitled. Second, in circumstances in which a
    1
    Notably, hospice payments are also subject to a separate “inpatient
    cap,” which limits reimbursement for inpatient services to “20 percent of
    the aggregate number of days” in a year that a Medicare beneficiary
    received hospice care. 42 U.S.C. § 1395x(dd)(2)(A)(iii). This cap also
    cannot be applied until the end of the year, reinforcing the agency’s
    decision to interpret “amount of payment made” as a year-end
    determination, and belying plaintiffs’ argument that overpayment
    amounts can be calculated by comparing the aggregate cap and the sum
    of periodic reimbursements.
    22            SILVERADO HOSPICE V. BECERRA
    hospice exceeds the aggregate cap, the sequestration
    mandate requires the agency to reduce the amount that a
    hospice is entitled to after the application of the aggregate
    cap. Third, the Medicare statute does not specify that the
    aggregate cap must be subtracted from the sum of a
    hospice’s historical periodic reimbursements. Given these
    considerations, the agency reasonably instituted a
    sequestration method that is consistent with the text of both
    the Budget Control Act and the Medicare statute. The
    agency’s method gives effect to sequestration without
    impermissibly altering the calculation of the aggregate cap.
    See Epic Sys. Corp. v. Lewis, 
    138 S. Ct. 1612
    , 1619 (2018)
    (explaining that courts have a “duty to interpret Congress’s
    statutes as a harmonious whole rather than at war with one
    another”).
    Plaintiffs’ further arguments to the contrary are
    unpersuasive. The agency’s sequestration method is not
    inconsistent with 
    42 C.F.R. § 418.308
    (d), which simply
    states that “[p]ayments made to a hospice during a cap period
    that exceed the cap amount are overpayments and must be
    refunded.” This regulation did not purport to interpret
    “amount of payment made” in § 1395f(i)(2)(A). The same
    is true of the non-binding description in the then-operative
    version of the Medicare Benefit Policy Manual, ch. 9, § 90.2.
    Both sources merely confirmed that the payment to which a
    hospice is legally entitled in a fiscal year is limited by the
    aggregate cap.
    Finally, we note that our decision is fully consistent with
    the conclusions of the only other federal court of appeals to
    address the interplay between the Budget Control Act’s
    sequestration mandate and the Medicare statute’s
    reimbursement provisions for hospice care. Earlier this year,
    the D.C. Circuit affirmed a district court’s grant of summary
    SILVERADO HOSPICE V. BECERRA                   23
    judgment to the government on a hospice provider’s
    identical challenge to CMS’s sequestration method.
    Gentiva, 31 F.4th at 768, 777. Gentiva held that the agency’s
    “methodology comports with the statutory text, purpose, and
    operation,” and “harmonizes the Medicare statute with the
    requirements of the Budget Control Act.” Id. at 777, 779.
    Our analysis accords with that of the D.C. Circuit.
    III
    Plaintiffs have raised one final issue: whether the agency
    was required to undertake notice-and-comment rulemaking
    before implementing the Budget Control Act’s sequestration
    mandate. Like the D.C. Circuit, see id. at 780–81, we reject
    this argument as well.
    The Medicare statute requires that a “rule, requirement,
    or other statement of policy . . . that establishes or changes a
    substantive legal standard governing . . . the payment for
    services . . . under this subchapter” (i.e., under Medicare)
    must be “promulgated by the Secretary by regulation.”
    42 U.S.C. § 1395hh(a)(2). And any such regulation is also
    subject to a 60-day notice-and-comment period. Id.
    § 1395hh(b)(1).
    The agency’s sequestration method, as reflected in the
    TDL and the PRRB’s decisions, did not amount to the
    “establish[ment]” or “change[]” of a substantive legal
    standard governing payment for services under Medicare,
    within the meaning of § 1395hh. Rather, Congress enacted
    the Budget Control Act’s sequestration requirements, and
    the President implemented sequestration when the statutory
    conditions were triggered. It was not the agency that
    established or changed any legal standard, but Congress that
    directed the agency to reduce its spending through the
    24            SILVERADO HOSPICE V. BECERRA
    Budget Control Act. The agency simply abided by
    congressional and presidential directives.
    Plaintiffs’ invocation of Azar v. Allina Health Services,
    
    139 S. Ct. 1804
     (2019), is unpersuasive. In Allina, the
    Supreme Court held that a new Medicare reimbursement
    policy was subject to notice-and-comment rulemaking,
    rejecting the agency’s argument that the new policy was
    exempt because it was merely filling a “gap” left by the
    Medicare statute and its existing regulations. 139 S. Ct.
    at 1817. Allina explained that “when the government
    establishes or changes an avowedly ‘gap’-filling policy, it
    can’t evade its notice-and-comment obligations.” Id.
    But Allina specifically left open what would happen if
    “the statute itself required” the agency to establish or change
    a substantive legal standard. 139 S. Ct. at 1816. Since
    Allina, we have rejected a challenge to a MAC’s local
    coverage determination on this basis, holding that the
    statutorily required coverage determinations did not
    “‘establish or change’ the standard for reimbursement
    contained in the statute itself,” so the plaintiff’s “reliance on
    Allina [was] therefore misplaced.” Agendia, Inc. v. Becerra,
    
    4 F.4th 896
    , 902 (9th Cir. 2021). Here, the agency was not
    establishing a gap-filling policy under the Medicare statute
    but implementing a new directive required under a separate
    statute: the Budget Control Act. See Gentiva, 31 F.4th
    at 780–81 (“When CMS adopted the sequestration
    methodology, it did not act pursuant to its authority to
    effectuate the Medicare statute, but rather pursuant to the
    mandate of the Budget Control Act.”). Notice-and-comment
    rulemaking under § 1395hh was not required.
    *   *    *
    SILVERADO HOSPICE V. BECERRA   25
    The judgment of the district court is
    AFFIRMED.